border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


  • Product Description
  • Once a report has been filed with the SEC it will be available on the website.



  • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this 8-K on 12/29/2010.
               Outline Printer Friendly Entire FilingNext Page »

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

     

    WASHINGTON, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT NVDLRT PURSUANT

    TO SECTION 13 OR 15(D) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of report (Date of earliest event reported): December 20, 2010

     

     

    NOVADEL PHARMA INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

     

     

     

    Delaware

     

    001-32177

     

    22-2407152

    (State or other jurisdiction

    of incorporation or organization)

     

    (Commission File No.)

     

    (I.R.S. Employer

    Identification No.)

     


    1200 Route 22 East, Suite 2000

    Bridgewater, NJ 08807

    (Address of principal executive offices) (Zip Code)

     

    (908) 203-4640

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

     

    o

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    o

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    o

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    o

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

     



    Item 8.01.       Other Events.

    On December 20, 2010, the stock quotation for NovaDel Pharma Inc., a Delaware corporation (the “Company”), under the symbol “NVDL” was deleted from the OTC Bulletin Board (the “OTCBB”). The symbol was deleted for factors beyond the Company’s control. Pursuant to Rule 15c2-11, the Company was deemed to be deficient in maintaining a listing standard at the OTCBB because the Company did not have a sufficient number of market makers providing quotes on the Company’s common stock on the OTCBB for four consecutive trading days. That determination was made entirely without the Company’s knowledge.

     

    The Company’s common stock now trades exclusively on the OTCQB under the symbol “NVDL.” The OTCQB is a new electronic interdealer quotation system created by Pink OTC Markets, Inc, comparable to the OTCBB whereby all Securities and Exchange Commission (“SEC”) registered companies quoted on the OTC market are eligible to trade.

     

    The Company’s shares remain tradable under the symbol “NVDL” on OTCQB. Investors can obtain a quote on the Company’s common stock by going to www.otcmarkets.com, and searching under the symbol “NVDL.”

     

    The Company is seeking a new market maker to file a new Form 211 application with the Financial Industry Regulatory Authority (“FINRA”) in order to have the Company’s common stock reinstated on OTCBB.

     

    The Company remains current in all its required SEC filings and with the regulators in the jurisdictions in which it operates.

     

     







    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer